Primate Lentiviral Vpx Commandeers DDB1 to Counteract a Macrophage Restriction
暂无分享,去创建一个
[1] P. Bieniasz,et al. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu , 2008, Nature.
[2] Xiao-Fang Yu,et al. DDB1 and Cul4A Are Required for Human Immunodeficiency Virus Type 1 Vpr-Induced G2 Arrest , 2007, Journal of Virology.
[3] M. Washburn,et al. Lentiviral Vpr usurps Cul4–DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle , 2007, Proceedings of the National Academy of Sciences.
[4] A. Finzi,et al. HIV-1 Vpr-Mediated G2 Arrest Involves the DDB1-CUL4AVPRBP E3 Ubiquitin Ligase , 2007, PLoS pathogens.
[5] E. Zimmerman,et al. HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system , 2007, Virology Journal.
[6] E. Wiertz,et al. Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3 , 2007, The Journal of cell biology.
[7] Jean-Christophe Rain,et al. HIV1 Vpr Arrests the Cell Cycle by Recruiting DCAF1/VprBP, a Receptor of the Cul4-DDB1 Ubiquitin Ligase , 2007, Cell cycle.
[8] P. Cascio,et al. Proteasome activity restricts lentiviral gene transfer into hematopoietic stem cells and is down-regulated by cytokines that enhance transduction. , 2006, Blood.
[9] T. Hope,et al. Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[10] L. McGinnes,et al. Inhibition of Receptor Binding Stabilizes Newcastle Disease Virus HN and F Protein-Containing Complexes , 2006, Journal of Virology.
[11] B. Cullen. Role and Mechanism of Action of the APOBEC3 Family of Antiretroviral Resistance Factors , 2006, Journal of Virology.
[12] K. Cadwell,et al. Ubiquitination on Nonlysine Residues by a Viral E3 Ubiquitin Ligase , 2005, Science.
[13] J. Garcia,et al. Inhibition of Lysosome and Proteasome Function Enhances Human Immunodeficiency Virus Type 1 Infection , 2005, Journal of Virology.
[14] F. Bushman,et al. Cell Cycle Arrest in G2/M Promotes Early Steps of Infection by Human Immunodeficiency Virus , 2005, Journal of Virology.
[15] Reuben S. Harris,et al. Retroviral restriction by APOBEC proteins , 2004, Nature Reviews Immunology.
[16] M. Carrington. Faculty Opinions recommendation of Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. , 2002 .
[17] M. L. Penn,et al. HIV-1 Vpr Enhances Viral Burden by Facilitating Infection of Tissue Macrophages but Not Nondividing CD4+ T Cells , 2001, The Journal of experimental medicine.
[18] D. Kabat,et al. Cellular and Viral Specificities of Human Immunodeficiency Virus Type 1 Vif Protein , 2000, Journal of Virology.
[19] Navid Madani,et al. An Endogenous Inhibitor of Human Immunodeficiency Virus in Human Lymphocytes Is Overcome by the Viral Vif Protein , 1998, Journal of Virology.
[20] M. Malim,et al. Evidence for a newly discovered cellular anti-HIV-1 phenotype , 1998, Nature Medicine.
[21] M. Malim,et al. HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. , 1998, Science.
[22] B. Hahn,et al. Differential association of uracil DNA glycosylase with SIVSM Vpr and Vpx proteins. , 1998, Virology.
[23] Bertrand Friguet,et al. Antiviral Activity of the Proteasome on Incoming Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.
[24] P. Sharp,et al. Nuclear import and cell cycle arrest functions of the HIV‐1 Vpr protein are encoded by two separate genes in HIV‐2/SIV(SM). , 1996, The EMBO journal.
[25] F. Rey,et al. Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme , 1996, Journal of virology.
[26] D O Morgan,et al. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity , 1995, Journal of virology.
[27] J. Luban,et al. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B , 1995, Journal of virology.
[28] Satoshi Omura,et al. Degradation of CFTR by the ubiquitin-proteasome pathway , 1995, Cell.
[29] Meng Chen,et al. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle , 1995, Journal of virology.
[30] M. Emerman,et al. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection , 1995, Journal of virology.
[31] R. Connor,et al. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. , 1995, Virology.
[32] M. Emerman,et al. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[33] D. Kolson,et al. Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate. , 1994, Virology.
[34] L. Ratner,et al. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions , 1993, Journal of virology.
[35] J. Mullins,et al. Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14 , 1990, Nature.
[36] J. Sodroski,et al. Human immunodeficiency virus vpr product is a virion-associated regulatory protein , 1990, Journal of virology.
[37] L. Hood,et al. Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIVMAC , 1988, Journal of virology.
[38] K. Überla,et al. Retrovirology BioMed Central , 2008 .
[39] L. Van Aelst,et al. Lentiviral delivery of RNAi in hippocampal neurons. , 2006, Methods in enzymology.
[40] John L. Sullivan,et al. Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy , 2000, Nature Medicine.